A

Avadel Pharmaceuticals plc
D

AVDL

8.41000
USD
-0.06
(-0.65%)
مغلق
حجم التداول
39,192
الربح لكل سهم
0
العائد الربحي
-
P/E
-11
حجم السوق
810,400,450
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGIO
    1.430
    (4.23%)
    35.210 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BPMC
    -2.080
    (-2.20%)
    92.280 USD
    E
    EXEL
    1.750
    (4.99%)
    36.830 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    P
    PBYI
    -0.01500
    (-0.51%)
    2.90500 USD
    المزيد
الأخبار
المقالات

العنوان: Avadel Pharmaceuticals plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.